Surmodics, Inc.

NASDAQ:SRDX   4:00:00 PM EDT
36.13
+1.21 (+3.46%)
4:09:32 PM EDT: $36.13 0.00 (0.00%)
Other Pre-Announcement

Surmodics Introduces Fiscal Year 2023 Financial Guidance

Published: 11/09/2022 12:30 GMT
Surmodics, Inc. (SRDX) - Surmodics Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Financial Guidance.
Surmodics Inc Q4 GAAP Loss per Share $1.06.
Surmodics Inc Q4 Revenue Rose 8 Percent to $26.0 Million.
Surmodics Inc Q4 Non-GAAP Loss per Share $0.26.
Surmodics Inc - Expects Fiscal Year 2023 Total Revenue to Range From $103 Million to $107 Million.
Surmodics Inc - Expects Fiscal 2023 GAAP Diluted Loss per Share to Range From $2.80 to $2.40.
Surmodics Inc - Non-GAAP Diluted Loss per Share in Fiscal 2023 is Expected to Range From $2.54 to $2.14.